Here are five things to know about the process, according to an Oct. 3 news release from CMS:
- Abbott formally requested the national coverage analysis in a 2023 letter.
- Transcatheter edge-to-edge repair (TEER) is used to treat mitral regurgitation. T-TEER applies similar technology to the treatment of tricuspid valve regurgitation.
- CMS is soliciting public comment, including scientific evidence and peer-reviewed literature, as part of the coverage analysis.
- The public comment period ends Nov. 2.
- CMS expects to complete its analysis by July 2.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
